000 01134 a2200313 4500
005 20250518062156.0
264 0 _c20191028
008 201910s 0 0 eng d
022 _a1873-4294
024 7 _a10.2174/1568026619666190712210903
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFelsing, Daniel E
245 0 0 _aAdvances in Dopamine D1 Receptor Ligands for Neurotherapeutics.
_h[electronic resource]
260 _bCurrent topics in medicinal chemistry
_c2019
300 _a1365-1380 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDopamine Agonists
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aLigands
650 0 4 _aMental Disorders
_xdrug therapy
650 0 4 _aMolecular Structure
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aReceptors, Dopamine D1
_xagonists
700 1 _aJain, Manish K
700 1 _aAllen, John A
773 0 _tCurrent topics in medicinal chemistry
_gvol. 19
_gno. 16
_gp. 1365-1380
856 4 0 _uhttps://doi.org/10.2174/1568026619666190712210903
_zAvailable from publisher's website
999 _c30143596
_d30143596